Skip to content

Simulation of Consecutive Day Shift Work

Simulation of Consecutive Day Shift Work

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04625634
Enrollment
23
Registered
2020-11-12
Start date
2019-12-02
Completion date
2022-05-01
Last updated
2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue; Heat, Hyperthermia

Brief summary

The purpose of this study is to determine differences in physiological recovery between two consecutive days of simulated fire suppression work. The secondary purpose is to determine differences in heat gain and heat loss between two consecutive days of simulated fire suppression work. Subjects will complete two consecutive days of simulated structural firefighting shift work, 24 hours apart. Before and after each laboratory visit, subjects will continuously wear a Holter monitor and ambulatory blood pressure monitor to quantify parasympathetic tone and recovery from work.

Interventions

OTHER2 days of work heat stress

2 consecutive days of identical simulated structural firefighting tasks.

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Repeated measures study

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-39 y old men and women * Self-reported to be healthy

Exclusion criteria

* History of any cardiovascular, neurologic, renal, or metabolic disease * Current tobacco use or regular use within the last 2 years * Taking medications with known thermoregulatory or cardiovascular effects (e.g., aspirin, acetaminophen, ibuprofen, beta blockers, diuretics, psychotropics, etc.) * History of exertional heat stroke * Currently pregnant or breastfeeding, or planning to become pregnant during the study * Inability to follow the rules of the protocols or understand the consent form * No contraindications for ingestion of the gastrointestinal temperature pill

Design outcomes

Primary

MeasureTime frameDescription
Core temperature20 minutesGastrointestinal temperature measured with an ingestable pill.
Heart rate20 minutesHeart rate measured with a wearable heart rate strap and monitor

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026